A study using a large sample of agreements between sponsors of clinical trials and clinical investigators suggests that it should be feasible for statistical agencies to develop a producer price index for biomedical research-and-development activities.
No takes yet. Share an insight, caveat, or question.
Berndt et al. (2013) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: